If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Intuitive reported revenue of $6.431B last year. Estimated global market for surgical robots was $8.5B. That works out at 75.7% share of total revenue - extremely impressive, although substantially less than "over 90%" in terms of revenue.
If they are interested in taking over CREO, they have shown no sign of it so far - not participating in the fundraising, for example - but it should be noted that they are really just evaluating the usage of CREOs tools at the moment, if they like them for any specific application then the uptake could be swift and dramatic. Also, although huge, they are not the only big player in this area, and there is at least one smaller, nimbler rival who also have a contract with CREO, which could lead to big European sales. On top of that, the global market is predicted to more than double over the next four years.
Some good reasons to be positive on this stock, with the usual cautions and awareness of recent CREO history and disappointments.
We know that Creo is partnered with Intuitive, which has sewn up over 90% of the world surgical robotics market. Intuitive has a market cap of $115 billion and trades on a P/E ratio of around 100. Incredible numbers. It would seem that the Creo suite of instruments offers Intuitive genuine and real advantages, certainly this is what Creo itself is saying. That being the case it would be no surprise if Intuitive took out Creo, particularly given the opportunity to do so at maybe half Creo’s peak valuation. Or looking at it another way it is almost a concern that they haven’t!
Agreed, really frustrating. I thought I had a bargain when I bought and have had to heavily average down. Hoping now that we should be funded to profitability, with the amount of news to potentially drop (eg fda approval for spydrblade should be due this year- according to a proactive video) & hopefully some positive numbers on adoption we can get back to where we should be (and i can have shares back in profit).
Long term holders have been shafted by misjudgement, of course. If they had fundraised when it was obviously needed, then the long SP decline and heavy dilution could have been substantially reduced. The fundraising issue was highlighted on this board long before it destroyed 90% of shareholder value: if we could see it, why couldn't the people who are paid to?
That's brilliant both of you many thanks!. Just gives me a bit of context as to how things might go (all things being well of course) just to get back to where the MCAP was historically. I bought in around the 30p mark so no champagne corks yet but maybe the odd beer or two on the back of things so far :).
Hi 1eyedman
Before the fundraising in Feb, there were 180 million shares in issue, so at £2.20 the MCAP would have been approx £396m. That seems to demonstrate the potential for this to go much higher if the revenue numbers are pleasing.
Those who bought at 20p got an absolute steal!
Don't know the highest market cap so far, but they released an rns 30th April 2021, number of shares in issue at that date were 157, 940, 390, share price was 1. 9863, so market cap of around 313.7m
The crowd go wild!. Or are quietly county their cash. I wonder can any of the long term holders tell me very roughly what the MCAP of the company was back in (say) March '22 when the share price was around £2.20?. Whilst its easy enough to look up a historical share price the issuing of shares on AIM stocks mean historical MCAPS are more difficult to work out. A best guess ballpark would be fine or even a best (educated) guess at the highest ever MCAP so far?.
Cheers
MCAP is only £88.6M, so it's a confident punt, if you'll pardon my language.
Presumably institutional: Cannacord or M&G maybe?
Over £1m bought in two chunks today, and a string of other decent buys make it look as if something's afoot here.
Starresnstoff. Useful link thank you.
David. With respect to time scale. No idea in all honesty,I would guess months rather than weeks or years. The NICE website does mention 39weeks for technological appraisal process. Seems an odd number and is probably an average. The outcome is obviously very important either way. Good luck with your investment!.
Recently dipped toe in with 20k shares. There is a lot happening including the latest RNS on NICE review. How long does this kind of review take - any ideas?
Oldogg
you got another one now
https://www.proactiveinvestors.co.uk/companies/news/1016232/creo-medical-group-really-pleased-with-first-human-trial-of-lung-lesion-treatment-1016232.html
Thanks for that Troajan.
Great news for CREO that their microwave ablation tool has been used against lung cancer lesions for the first time on a patient. Apparently this trial has been made possible by new screening techniques, a game changer in the fight against lung cancer. Potentially, this technology could obviate the need for chemotherapy and radiation for some patients. Congrats to all involved, especially heroic doctors at Royal Brompton Hospital
Sorry 1eyed, I completely missed that, even with two good eyes ( :
Yes, long termers here are possibly underwater and 'waving', but for new investors it could become a shiny speedboat
Sorry my wording was bad in my post. I was referring to a couple of £10k share buys which is pretty chunky as volumes are pretty thin. But I agree the ongoing revenue from sales from hospitals embracing the devices is encouraging.
The significance is how they've gone all in, very quickly, clearly seeing CREO's system as MUCH better than old methods in every respect - so not just a buy, but ongoing revenue. Assuming they successfully save money while improving patient outcomes, it seems like a no-brainer for lots of others to follow fairly swiftly?
A lot of work to do to get more hospitals on board with the devices but so far so good. Couple of fairly decent buys someone likes it.
Nice to see the company heading in the right direction 👍
Known this company since its inception as Microoncology. Extreme talent will be a longer-term investment. Not for the city quick buck brigade!
Another useful link-thank you. Nice to see the last raise confidently referred to as 'final', although it risks something of a credibility issue should this not prove to be the case.
@Faicj -Welcome and GL I hope you make lots of money :).
https://www.proactiveinvestors.co.uk/companies/news/1014104/creo-medical-group-knows-what-it-needs-to-do-after-terrific-2022-1014104.html
1eyedman
getting a mine in production,is a nightmare.
loads fail,because for whatever reason,tonnages/recovery rates....cant be achieved
rmm,failed,just recently.....and capex costs,are off the scale,$100 million,gets you a small mine nowarday